drug recalls

March 2025 Drug Safety Part 2: New warnings for MRI contrast agents; Baqsimi, Belsomra, Furoscix, Iluvien ophthalmic, Metronidazole; Recalls…

(Jump to recalls announcements)

Mar 23

December 2024 Drug Safety Updates: Antidepressant and seizure drug recalls; Ocaliva and liver failure; new acne inversa med's label change…

Drug Recalls: Duloxetine and Clonazepam

Dec 15, 2024 •

October 2024 Drug Safety Update Part 1: Sickle cell drug withdrawn; Quviviq, Aldara, Xeljanz, Dupixent and cancer drugs; breast feeding and…

Consumer-friendly summaries of new safety information added to FDA drug labels

Oct 6, 2024 •

Drug Safety Labeling Changes: May 2024 Part 2

Bupropion, cancer drug Imbruvica, R.A. med Xeljanz, fertility treatment follitropin, antipsychotic Rexulti, Philips Respironics Trilogy Evo ventilators

May 19, 2024

Drug Safety Updates: April 2024 Part 2 Labeling changes for Entresto, Dupixent, CAR-T therapies; Dangers of “Gas Station Heroin”(tianeptine…

Drug Safety Label Changes: Entresto and Dupixent

Apr 21, 2024 •

Drug Safety Updates March 2024: Part 2

Drug Quality Testing Project

Mar 17, 2024 •

Drug Safety Updates: March 2024

Notable FDA Safety announcements and label changes

Mar 3, 2024 •

Drug Safety January 2024 FDA Labeling Updates & Recalls

Jan 21, 2024

October 15, 2023: New drugs for lung cancer, ulcerative colitis; Prilosec-Nexium settlement; nitrosamine drug recall update; IBS podcast…

New Drug Approvals

Oct 15, 2023

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts